Cargando…

Investigating the Role of African Horse Sickness Virus VP7 Protein Crystalline Particles on Virus Replication and Release

African horse sickness is a deadly and highly infectious disease of equids, caused by African horse sickness virus (AHSV). AHSV is one of the most economically important members of the Orbivirus genus. AHSV is transmitted by the biting midge, Culicoides, and therefore replicates in both insect and m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bekker, Shani, Potgieter, Christiaan A., van Staden, Vida, Theron, Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608501/ https://www.ncbi.nlm.nih.gov/pubmed/36298748 http://dx.doi.org/10.3390/v14102193

Ejemplares similares

Generation of a Soluble African Horse Sickness Virus VP7 Protein Capable of Forming Core-like Particles
por: Bekker, Shani, et al.
Publicado: (2022)

Characterising Non-Structural Protein NS4 of African Horse Sickness Virus
por: Zwart, Lizahn, et al.
Publicado: (2015)

Establishment of different plasmid only-based reverse genetics systems for the recovery of African horse sickness virus
por: Conradie, Andelé M., et al.
Publicado: (2016)

VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV
por: van de Water, Sandra G. P., et al.
Publicado: (2015)

Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus
por: Kanai, Yuta, et al.
Publicado: (2014)

Assessment of reproducibility of a VP7 Blocking ELISA diagnostic test for African horse sickness
por: Durán‐Ferrer, Manuel, et al.
Publicado: (2018)

Consensus Sequence of 27 African Horse Sickness Virus Genomes from Viruses Collected over a 76-Year Period (1933 to 2009)
por: Potgieter, A. Christiaan, et al.
Publicado: (2015)

Assembly of Replication-Incompetent African Horse Sickness Virus Particles: Rational Design of Vaccines for All Serotypes
por: Lulla, Valeria, et al.
Publicado: (2016)

Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses
por: Dennis, Susan J., et al.
Publicado: (2018)

Protective efficacy of multivalent replication-abortive vaccine strains in horses against African horse sickness virus challenge
por: Lulla, Valeria, et al.
Publicado: (2017)

Real Time RT-PCR Assays for Detection and Typing of African Horse Sickness Virus
por: Bachanek-Bankowska, Katarzyna, et al.
Publicado: (2014)

Evidence of Intragenic Recombination in African Horse Sickness Virus
por: Ngoveni, Harry G., et al.
Publicado: (2019)

The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host
por: Calvo-Pinilla, Eva, et al.
Publicado: (2018)

African Horse Sickness Virus Serotype 1 on Horse Farm, Thailand, 2020
por: Bunpapong, Napawan, et al.
Publicado: (2021)

A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model
por: Aksular, Mine, et al.
Publicado: (2018)

Adaptive strategies of African horse sickness virus to facilitate vector transmission
por: Wilson, Anthony, et al.
Publicado: (2009)

Pathological features of African horse sickness virus infection in IFNAR(−/−) mice
por: Jones, Luke M., et al.
Publicado: (2023)

Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge
por: Alberca, Berta, et al.
Publicado: (2014)

A Modified Vaccinia Ankara Virus (MVA) Vaccine Expressing African Horse Sickness Virus (AHSV) VP2 Protects Against AHSV Challenge in an IFNAR −/− Mouse Model
por: Castillo-Olivares, Javier, et al.
Publicado: (2011)

Sero-epidemioloical survey on African horse sickness virus among horses in Khartoum State, Central Sudan
por: Karamalla, Siham T., et al.
Publicado: (2018)

B-cell epitopes of African horse sickness virus serotype 4 recognised by immune horse sera
por: Mathebula, Evans M., et al.
Publicado: (2017)

Entry-competent-replication-abortive African horse sickness virus strains elicit robust immunity in ponies against all serotypes
por: Sullivan, Edward, et al.
Publicado: (2021)

Immunogenicity of plant‐produced African horse sickness virus‐like particles: implications for a novel vaccine
por: Dennis, Susan J., et al.
Publicado: (2017)

Requirements and comparative analysis of reverse genetics for bluetongue virus (BTV) and African horse sickness virus (AHSV)
por: van Rijn, Piet A., et al.
Publicado: (2016)

Production of foot-and-mouth disease virus SAT2 VP1 protein
por: Mamabolo, Mpho Victoria, et al.
Publicado: (2020)

Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness
por: Rutkowska, Daria A., et al.
Publicado: (2019)

Immune response of horses to inactivated African horse sickness vaccines
por: Rodríguez, Marina, et al.
Publicado: (2020)

Correction: Real Time RT-PCR Assays for Detection and Typing of African Horse Sickness Virus
Publicado: (2014)

Reverse genetics approaches: a novel strategy for African horse sickness virus vaccine design
por: Calvo-Pinilla, Eva, et al.
Publicado: (2020)

Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48 h before, or 48 h after challenge
por: Calvo-Pinilla, Eva, et al.
Publicado: (2015)

Ecological niche modeling predicting the potential distribution of African horse sickness virus from 2020 to 2060
por: Assefa, Ayalew, et al.
Publicado: (2022)

Clinical, Virological and Immunological Responses after Experimental Infection with African Horse Sickness Virus Serotype 9 in Immunologically Naïve and Vaccinated Horses
por: Durán-Ferrer, Manuel, et al.
Publicado: (2022)

Comparative immune responses after vaccination with the formulated inactivated African horse sickness vaccine serotype 1 between naïve horses and pretreated horses with the live-attenuated African horse sickness vaccine
por: Chaiyabutr, Narongsak, et al.
Publicado: (2022)

Co-infection of Peruvian horse sickness virus and West Nile virus associated with neurological diseases in horses from Brazil
por: Patroca da Silva, Sandro, et al.
Publicado: (2022)

A review of African horse sickness and its implications for Ireland
por: Thompson, Geoffrey M, et al.
Publicado: (2012)

Seroprevalence of African horse sickness in selected donkey populations in Namibia
por: Molini, Umberto, et al.
Publicado: (2020)

African horse sickness in Thailand: Challenges of controlling an outbreak by vaccination
por: Castillo‐Olivares, Javier
Publicado: (2020)

Addressing the recent outbreak of African horse sickness in Lagos, Nigeria
por: Adesola, Ridwan Olamilekan, et al.
Publicado: (2023)

Worldwide Niche and Future Potential Distribution of Culicoides imicola, a Major Vector of Bluetongue and African Horse Sickness Viruses
por: Guichard, Sylvain, et al.
Publicado: (2014)

An entry risk assessment of African horse sickness virus into the controlled area of South Africa through the legal movement of equids
por: Grewar, John D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_179b7b3f02aso2c6nmhfjk7qof